Fitch Assigns "A-" Rating to Thermo Fisher's Planned Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following Thermo Fisher Scientific's announcement today that it will issue senior notes to fund in part its $3.5 billion acquisition of Phadia, ratings agency Fitch assigned an "A-" rating to the notes.

Thermo Fisher has not yet disclosed the terms of the notes or how much it expects to raise in the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.

Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.